Capital International Investors
AGL icon

Capital International Investors’s Agilon Health AGL Stock Holding History

Capital International Investors’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-329,288
Closed -$8.48M – 455
2025
Q3 		$8.48M Sell
329,288
-66,422
-17% -$2.51M ﹤0.01% 406
2025
Q2 		$22.8M Sell
395,710
-497,565
-56% -$39.9M ﹤0.01% 388
2025
Q1 		$96.7M Hold
893,275
– – 0.02% 282
2024
Q4 		$42.4M Buy
893,275
+373,852
+72% +$22.6M 0.01% 352
2024
Q3 		$51M Buy
519,423
+21,658
+4% +$2.8M 0.01% 323
2024
Q2 		$81.4M Sell
497,765
-310,152
-38% -$44.2M 0.02% 282
2024
Q1 		$123M Buy
807,917
+370,532
+85% +$61.7M 0.02% 263
2023
Q4 		$137M Buy
437,385
+60,879
+16% +$22M 0.03% 253
2023
Q3 		$167M Buy
376,506
+229
+0.1% +$103K 0.04% 230
2023
Q2 		$163M Buy
376,277
+234,787
+166% +$132M 0.04% 249
2023
Q1 		$84M Buy
+141,490
New +$79.2M 0.02% 305

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors's AGL Position: Q4 2025 in Review

Capital International Investors sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 329,288 shares — an estimated $8.48M sold.

Capital International Investors first reported a position in AGL in Q1 2023 and held it in 11 quarters. The position peaked at $167M in Q3 2023. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

  • Capital International Investors reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
  • Capital International Investors sold 329,288 Agilon Health shares in Q4 2025, an estimated $8.48M.
  • Capital International Investors first reported a position in Agilon Health in Q1 2023 and held it in 11 quarters.
  • Capital International Investors's Agilon Health position peaked at $167M in Q3 2023.
  • 194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on Capital International Investors's 13F filing for Q4 2025, filed 11 Feb 2026.